Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MDS and AML Prior to Allogeneic SCT”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Looking for participantsNCT07532824
What this trial is testing

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLProton Therapy+2 more
Institute of Hematology and Blood Transfusion, Czech Republic 16
Not applicableStudy completedNCT01746147
What this trial is testing

Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial

Who this might be right for
MDS and AML Prior to Allogeneic SCT
GWT-TUD GmbH 134

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation